• TEXT SIZE

Starting ENBREL

Take the first steps.

If you just began treatment with ENBREL, you've come to the right place. Use these tips to get started:

Download

Begin with your Starter Kit.

The Starter Kit is designed to give you a quick, 3-step start.

Inside, you'll find details to help you:

  1. Enroll in ENBREL Support so you can take advantage of all the benefits available at no cost to you
  2. Activate your ENBREL Support™ Card for assistance with co-pay costs
  3. Get answers to frequently asked questions

Get support when you need it.

When you take ENBREL, you have access to ENBREL Support, a program that offers a variety of patient resources at no cost to you, including:

  • Registered nurses to help answer your questions, available 8 am to 11 pm (ET), 7 days a week
  • ENBREL Nurse Partnerswho offer you support at home, by phone, email, or web video chat
  • Insurance specialists to answer your questions about coverage, available Monday–Friday, 8 am to 8 pm (ET)
  • Newsletters and e-mails with important information about what you may expect while taking ENBREL
Sign up now

Help with out-of-pocket costs.

The ENBREL Support™ Card has helped more than 200,000 people.
For all eligible* patients, the ENBREL Support™ card offers:

Card can be renewed every year. See eligibility criteria and limits.

Apply now

Are you on Medicare or uninsured? See how we can help.

Get injection help.

After you receive injection training from a healthcare professional, you can get additional support by calling 1-888-4ENBREL.

  • Order sharps disposal containers from the Sharps Mail-Back Program
  • Sign up for injection and prescription refill reminders
Watch injection demos

Get live help whenever you need it.

Call 1-888-4ENBREL (1-888-436-2735) or Schedule a call

Close

Schedule a call with a friendly support specialist when it's convenient for you

We can provide answers to questions about ENBREL treatment and support programs

Our registered nurses are available 8 AM to 11 PM (ET), 7 days a week, and our insurance and general information specialists
are available 8 AM to 8 PM (ET), Monday through Friday. Live support is available in over 200 languages. If this is a medical emergency, please call 911.
Please only request this call regarding your treatment or the treatment of a child in your care.

Patient Information
Indicates Required Field
  
Call Information
Estimated callback time: about an hour
We appreciate your patience.
At this time, we may not be able to get back to you until tomorrow.
If you would like a scheduled appointment, please click below.
Schedule a time to call that is convenient for you
busy
Close

Thanks, .

We'll get back to you as soon as possible. (Estimated callback time: about an hour)

If this is a medical emergency, please call 911.

Close

Thanks, .

You scheduled a call for Monday, March 1st at 9:15 am (ET).

If this is a medical emergency, please call 911.

Prescription ENBREL is taken by injection.

IMPORTANT SAFETY INFORMATION
Indications

Moderate to Severe Rheumatoid Arthritis (RA)
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderate to severe rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.

Moderately to Severely Active Polyarticular Juvenile Idiopathic Arthritis (JIA)
ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in children ages 2 years and older.

Psoriatic Arthritis
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. ENBREL can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.

Ankylosing Spondylitis (AS)
ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.

Moderate to Severe Plaque Psoriasis
ENBREL is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.